Codexis Reports 2016 Fourth Quarter and Full Year Financial Results
Mar 09, 2017 21:06 pm UTC| Business
Achieves 2016 total revenues and gross margin guidance, introduces 2017 financial guidance Conference call begins at 4:30 p.m. Eastern time todayAccompanying slide presentation available on Investor section of company...
Codexis Reports 2016 Fourth Quarter and Full Year Financial Results
Mar 09, 2017 21:06 pm UTC| Business
Achieves 2016 total revenues and gross margin guidance, introduces 2017 financial guidance Conference call begins at 4:30 p.m. Eastern time todayAccompanying slide presentation available on Investor section of company...
Mar 09, 2017 21:06 pm UTC| Business
NEW YORK, March 09, 2017 -- At the end of the settlement date of February 28, 2017, short interest in2,345 Nasdaq Global MarketSM securities totaled 7,280,848,100 shares compared with 7,247,866,478 shares in2,351 Global...
Mar 09, 2017 21:06 pm UTC| Business
NEW YORK, March 09, 2017 -- At the end of the settlement date of February 28, 2017, short interest in2,345 Nasdaq Global MarketSM securities totaled 7,280,848,100 shares compared with 7,247,866,478 shares in2,351 Global...
LeMaitre Vascular to Present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017
Mar 09, 2017 21:06 pm UTC| Business
BURLINGTON, Mass., March 09, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Barclays Global Healthcare Conference on Tuesday, March 14, 2017 at the Loews...
LeMaitre Vascular to Present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017
Mar 09, 2017 21:06 pm UTC| Business
BURLINGTON, Mass., March 09, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Barclays Global Healthcare Conference on Tuesday, March 14, 2017 at the Loews...
KemPharm, Inc. Reports Fourth Quarter and Year End 2016 Results
Mar 09, 2017 21:06 pm UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Recent Clinical Development Regulatory Highlights: Reported Positive Data from Phase 1 Proof-of-Concept Clinical Trial...